Neuralink Postpones Second Brain Implant Surgery

Elon Musk’s Neuralink has canceled an operation to implant its device on a second patient. The reason is his state of health.

As Bloomberg reports, citing Michael Lawton, CEO of the Barrow Neurological Institute, the patient suffers from Lou Gehrig’s disease, an incurable disease that causes the degradation of nerve cells in the brain and spinal cord and ultimately leads to complete muscle paralysis.

As Lawton told the resource in a telephone interview, the patient had health problems that made such an operation impossible at the moment. The next candidate for the Neuralink clinical trial program is likely to undergo surgery next month at the Barrow Clinic.

“Selecting the right patient for a study like this is important,” Lawton said. “Everyone involved, both clinically and surgically, is committed to doing it properly.”

Neuralink’s approved clinical trial program includes operations on three patients with completion of the preliminary phase in 2026.